Psychiatric manifestations of levodopa.
D000328:Adult; D000339:Affect / Q000187:drug effects; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced*; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005712:Galvanic Skin Response / Q000187:drug effects; D006212:Hallucinations / Q000139:chemically induced*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D008956:Models, Chemical; D010919:Placebos; D011604:Psychoses, Alcoholic / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy / Q000378:metabolism; D012119:Respiration / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D013315:Stress, Psychological; D014149:Tranquilizing Agents / Q000627:therapeutic use
D010919:Placebos; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine